Difficulty: Medium
Average Score: 72%
Practice
Monthly injections of palivizumab, a RSV-specific monoclonal antibody, initiated just before the onset of the RSV season confers some protection from severe RSV disease. Palivizumab is indicated for some infants under 2 years old with all the following EXCEPT
Correct answer
A
Rationale
Palivizumab is for high-risk infants (B, C, D, E). Asthma (A) alone isn├óÔé¼Ôäót an indication, per AAP guidelines.